The problem: access to clinical trials for people with small cell lung cancer (SCLC)
New and improved treatments for SCLC are greatly needed, and these treatments begin with clinical trials. Several factors can make it hard for people with SCLC to join clinical trials. People with SCLC are more likely to be older, live farther from the center where they receive treatment, and face multiple co-morbidities than people with other types of lung cancer.
The SUCCEED study
SUCCEED will test whether a “direct-to-patient” approach, where people can provide blood samples directly from their own homes or nearby, makes it easier for individuals with SCLC to participate in blood research studies. SUCCEED will also survey people with SCLC to learn what matters most to them when making treatment decisions and choosing to participate in research.
SUCCEED’s results will help researchers design future studies that meet the needs of people with SCLC and are easier to participate in. The blood samples from SUCCEED will be “bio-banked” (stored) to support future research aimed at finding new treatments.
How can you help?
Your voice and experience matter. If you’re living with SCLC, consider joining the SUCCEED study. Participation is easy, and all parts of the study can be done in or near your home.
The study involves 2 simple steps:
- Complete a short survey to share about your experience and needs.
- Provide blood samples so researchers can learn whether more convenient study designs help more people with SCLC participate.
Learn more about eligibility and how to join the study.
How is GO2 involved?
This GO2-initiated study is being done in partnership with Dr. Christine Lovly, MD, PhD at Vanderbilt University Medical Center and the Addario Lung Cancer Medical Institute (ALCMI). SUCCEED is funded by a grant awarded to GO2 from Boehringer Ingelheim.